update from a phase 1 study of amg 757 in sclc
Published 3 years ago • 197 plays • Length 2:47Download video MP4
Download video MP3
Similar videos
-
2:21
a phase 1 study of amg 757
-
1:41
iasc wclc 2021: cx-2029 and amg 757 for lung cancer
-
5:38
amg 757: dll3 targeting, half-life extended bispecific t-cell engager immuno-oncology therapy, i...
-
51:59
facilitating progress in the treatment of sclc
-
1:24:26
assessing the impact of therapeutic advances in sclc
-
17:10
sclc: therapeutic progress or mirage?
-
1:10:02
watch dr goldman, leal, and owonikoko, discuss the latest sclc updates - https://bit.ly/3jkp0l5
-
17:13
new treatment opportunities for small cell lung cancer
-
2:09
updates in upfront systemic therapy for es-sclc
-
1:43
updated results from the caspian trial of durvalumab plus chemo in sclc
-
1:56
rovalpituzumab in small cell lung cancer (sclc)
-
2:20
patterns of relapse after radiotherapy in sclc and future treatment strategies
-
1:31:45
making the most of treatment advances in sclc
-
3:55
chrysalis trial update in nsclc
-
1:41
updated results of a phase 1a study of anti-pdl1, mpdl3280a, in urothelial bladder cancer
-
15:57
2021 west oncology | lung cancer | updates on immunotherapy and small cell lung cancer stage 4
-
2:24
the dll3-targeting bite, tarlatamab, for the treatment of sclc
-
2:37
outcomes of patients with sclc following surgical resection
-
1:04:50
a new era has begun in the treatment of sclc: navigating novel therapeutic options and strategies